首页> 外文会议>International Conference on Social science and Education Research >Correlation of Blood Lipid Profile, Blood Lipid Ratio and Cystatin C in Patients with Hyperthyroidism
【24h】

Correlation of Blood Lipid Profile, Blood Lipid Ratio and Cystatin C in Patients with Hyperthyroidism

机译:血脂谱,血脂率和胱抑素C对甲状腺功能亢进患者的相关性

获取原文

摘要

To investigate the correlation among serum lipids and their ratios and cystatin C (CysC) in patients with hyperthyroidism. authors respectively chose fifty patients of hyperthyroidism, subclinical hyperthyroidism and the control group. TC, TG and LDL-C in the hyperthyroidism and subclinical hyperthyroidism groups were significantly lower than those in the control group (P<0.01); TC/HDL-C, TG/HDL-C, LDL-C/HDL-C, LCI, and non-HDL-C in the hyperthyroidism group were significantly higher than those in the subclinical hyperthyroidism and control groups; TC/HDL-C and TG/HDL-C in the subclinical hyperthyroidism group were significantly higher those in the control group while LDL-C/HDL-C, LCI, and non-HDL-C were significantly lower than the control group. LCI decrease being the most significant followed by LDL-C/HDL-C. The thyroid hormones mostly correlated with TC, followed by non-HDL-C, LDL-C and LCI. The level of CysC in the hyperthyroidism and subclinical hyperthyroidism groups was significantly higher and there was also significant difference regarding this level between both groups (P<0.05). The author came to the conclusion that the changes of serum lipid ratios in patients with hyperthyroidism and subclinical hyperthyroidism were more obvious than single indicator; and their CysC level was also significantly higher than that of control group. Dynamic monitoring of blood lipid ratios and CysC level could be an optimized combination item for the transformation from subclinical hyperthyroidism to hyperthyroidism and prediction of hyperthyroidism complicated with CHD.
机译:研究甲状腺功能亢进患者血清脂质及其比例和胱抑素C(CYSC)的相关性。作者分别选择了甲状腺功能亢进,亚临床甲亢和对照组患者。甲状腺功能亢进症和亚临床甲状腺功能亢进组中的TC,TG和LDL-C显着低于对照组(P <0.01);甲状腺功能亢进组中的TC / HDL-C,TG / HDL-C,LDL-C / HDL-C,LCI和非HDL-C显着高于亚临床甲状腺功能亢进和对照组的基团;在亚临床甲状腺功能亢进组中的TC / HDL-C和TG / HDL-C在对照组中显着提高,而LDL-C / HDL-C,LCI和非HDL-C显着低于对照组。 LCI减少是最重要的,后跟LDL-C / HDL-C。甲状腺激素主要与TC相关,其次是非HDL-C,LDL-C和LCI。甲状腺功能亢进症和亚临床甲状腺功能亢进症中的CYSC水平显着升高,两组之间该水平也有显着差异(P <0.05)。作者得出结论,甲状腺功能亢进患者和亚临床甲状腺功能亢进患者血清脂质比的变化比单一指标更明显;他们的Cysc水平也明显高于对照组。动态监测血脂比和CYSC水平可以是优化的组合项目,用于从亚临床甲状腺功能亢进症转化到甲状腺功能亢进的转化和甲状腺功能亢进的预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号